* Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.
^† Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device.
^‡ Eligible customers must be 18 years or older and have Type 1 or Type 2 diabetes, private insurance, Medicare, or TRICARE. This program is not available for patients with gestational diabetes, patients with Kaiser insurance, patients with other types of government insurance, or patients without insurance.
^§ Free prescription home delivery is for standard shipping only. Express delivery requests may incur a fee.
^ǁ On May 8, 2020, CMS published a second interim final rule with comment, CMS-5531-IFC, that expanded the non-enforcement of clinical indications of coverage to therapeutic continuous glucose monitors (CGMs). (www.govinfo.gov/content/pkg/FR-2020-05-08/pdf/2020-09608.pdf) The Durable Medical Equipment Medicare Administrative Contractors (DME MAC) subsequently issued guidance on the IFC policies, including discussing that clinical indications for coverage in the therapeutic CGM LCD (Glucose Monitors, L33822) will not be enforced. See “CMS Issues Interim Final Rules with Comment (CMS-1744-IFC & CMS-5531-IFC) – COVID-19 Public Health Emergency – Revised May 21, 2020.” (www.cgsmedicare.com/jc/pubs/news/2020/05/cope1733)
^¶ Eligible patients will receive one (1) FreeStyle Libre 14 day sensor at $0 copay. The expiration date of the voucher is 30 days from the issue date. Limit one offer per lifetime. Only patients aged 18 years old or older are eligible to enroll in this program or to receive an offer. This program is not available for patients with gestational diabetes. This offer is void where prohibited by law. Abbott may modify or rescind this offer at any time without notice. The discounts are not available to beneficiaries of Medicare, Medicaid, or other federal or state healthcare programs or residents of Massachusetts or Puerto Rico and other US territories. The free sensor is provided as a sample and is limited to one free sensor per eligible person. The sensor cannot be re-sold nor submitted to any third party payer for reimbursements.
^# Based on the sensor being replaced once every 14 days, and scanned at least once every 8 hours.
^** The reader can capture data from the sensor when it is within 1 cm to 4 cm of the sensor.
^†† Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.
^‡‡ Benefits for FreeStyle Libre 14 day sensors apply to two 14 day sensors per month. Benefits for FreeStyle Libre 14 day reader apply to one 14 day reader. Void where prohibited by law. Abbott may modify, rescind, or revoke these benefits at any time without notice. These benefits are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs, or residents of US territories and possessions, except Puerto Rico. For Massachusetts residents, only those patients responsible for the full cost of the product may be eligible to receive these benefits. These benefits are only available at participating pharmacies, which are subject to change without notice. The actual amount a patient pays may vary. The FreeStyle Libre 14 day system requires a prescription.
^§§ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app. Use of the FreeStyle LibreLink app requires registration with LibreView, a service provided by Abbott and Newyu,Inc.
^ǁǁ The FreeStyle LibreLink app and the FreeStyle Libre and FreeStyle Libre 14 Day reader have similar but not identical features. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose. When using FreeStyle LibreLink app, access to a blood glucose monitoring system is required as the app does not provide one.
^¶¶ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of the LibreLinkUp app requires registration with LibreView, a service provided by Abbott and Newyu, Inc.
^## Calibration or coding not required by the user.
^*** The FreeStyle Libre and FreeStyle Libre 14 Day sensors communicate with the FreeStyle Libre and FreeStyle Libre 14 Day readers that started them or the FreeStyle LibreLink app that started it. A sensor started by the FreeStyle Libre and FreeStyle Libre 14 Day reader will also communicate with the FreeStyle LibreLink app once the FreeStyle LibreLink app is used to scan the sensor. Medicare coverage is available for FreeStyle Libre and FreeStyle Libre 14 day systems for cell phone use if FreeStyle LibreLink is used in conjunction with the FreeStyle Libre and FreeStyle Libre 14 day readers. Patients must meet Medicare eligibility coverage criteria. Local Coverage Article: Glucose Monitor Policy Article (A52464), May 2017.

Reference: 1. Haak, Thomas, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicentre, open-label randomised controlled trial. Diabetes Therapy 8.1 (2017): 55-73. 2.Data on file. Abbott Diabetes Care
As a courtesy to its customers, Abbott provides the most accurate and up-to-date information available, but it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage of payment for our products or reimburse customers for claims that are denied by third party payers.

ADC-12211 Ver 13.0 10/20